Kyverna Therapeutics (KYTX) Other Working Capital Changes (2023 - 2026)
Kyverna Therapeutics (KYTX) posted Other Working Capital Changes of -$503000.0 for Q1 2026, up 84.94% on a QoQ basis from -$3.3 million in Q4 2025, and up 47.77% year-over-year from -$340399.9 in Q1 2025.
Kyverna Therapeutics (KYTX) Other Working Capital Changes (2023 - 2026) Analysis & Trends
Kyverna Therapeutics' Other Working Capital Changes history runs 4 years deep, the most recent figure standing at -$503000.0 for Q1 2026.
- Quarterly Other Working Capital Changes rose 47.77% year-over-year to -$503000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.9 million (down 1.3% YoY) and the FY2025 annual result came in at -$3.3 million, down 39.18% from the prior year.
- Other Working Capital Changes was -$503000.0 for Q1 2026 at Kyverna Therapeutics, up from -$3.3 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $2.6 million in Q1 2024 and bottomed at -$3.1 million in Q2 2024.
- A 4-year average of $133384.6 and a median of $380000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 377.13% in 2025, while the deepest fall reached 416.07% in 2025.
- Kyverna Therapeutics' Other Working Capital Changes stood at -$463000.0 in 2023, then tumbled by 39.74% to -$647000.0 in 2024, then tumbled by 416.07% to -$3.3 million in 2025, then surged by 84.94% to -$503000.0 in 2026.
- Business Quant data shows KYTX's Other Working Capital Changes at -$503000.0 in Q1 2026, -$3.3 million in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Kyverna Therapeutics | 440.57 Mn | 440.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -503,000.00 |
| Mar 31, 2026 | -503,000.00 |
| Mar 31, 2026 | -503,000.00 |
| Dec 31, 2025 | -3.34 Mn |
| Dec 31, 2025 | -3.34 Mn |
| Dec 31, 2025 | -3.34 Mn |
| Sep 30, 2025 | 1.72 Mn |
| Sep 30, 2025 | 1.72 Mn |
| Sep 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | -758,000.00 |
| Jun 30, 2025 | -758,000.00 |
| Jun 30, 2025 | -758,000.00 |
| Mar 31, 2025 | -963,000.00 |
| Mar 31, 2025 | -963,000.00 |
| Mar 31, 2025 | -963,000.00 |
| Dec 31, 2024 | -647,000.00 |
| Dec 31, 2024 | -647,000.00 |
| Dec 31, 2024 | -647,000.00 |
| Sep 30, 2024 | -621,000.00 |
| Sep 30, 2024 | -621,000.00 |